Myomo, Inc. (MYO) Stock Analysis

Company Overview

The market values Myomo, Inc. (MYO) at $57.04M. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 194 employees.

The 52-week range on file runs from $0.61 to $1.89. MYO last closed at $1.44 on September 4, 2026. That is +$0.04 (+2.86%) against the previous close. The latest close sits 138.02% above that 52-week low.

Financial Health

In fiscal 2025, Myomo, Inc. reported revenue of $40.93M. That is +25.73% against the prior fiscal year, when revenue was $32.55M. The same year closed with a net loss of $15.57M. The reported profit margin is −33.53%. That is 31.8 percentage points below the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −0.35.

Across the 4 fiscal years on file, revenue moves from $15.56M in 2022 to $40.93M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 1.32. On price-to-sales that is 55.7% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The trailing one-year price return is +42.57%. Measured over 5 years, that is −34.44% a year compounded. The reported beta is 1.5. Annualized volatility over the trailing 9 years is 114.44%.

Growth & Income

The record shows no dividend for MYO.

2026 is still running; the price is +58.24% year to date. The strongest complete calendar year on file is 2023 at +880.43%; the weakest is 2022 at −92.53%. Of the 8 complete calendar years on file, 3 finished higher.